British drug maker Shire Pharmaceuticals Group on Monday said that a patent infringement lawsuit it filed against Nostrum Pharmaceuticals, a New Jersey-based drug company, will go to trial after a U.S. federal court judge denied Nostrum's motion for summary judgment seeking to dismiss the case. Shire said it sued Nostrum in 2003 after Nostrum filed a new drug application seeking regulatory approval for a generic version of Carbatrol, Shire's leading epilepsy treatment. In the lawsuit, Shire said it charged that Nostrum infringed upon one of its patents that claims the formulas which include Carbatrol.

Posted by GEN-ERIC at 12:03:52 am into the following categories: In The News

---

http://gen-eric.com/patents/htsrv/trackback.php/303

Name:

Email: (not displayed on this site)

Site/Url:

Comment text:

Allowed XHTML tags: <p, ul, ol, li, dl, dt, dd, address, blockquote, ins, del, a, span, bdo, br, em, strong, dfn, code, samp, kdb, var, cite, abbr, acronym, q, sub, sup, tt, i, b, big, small>

URLs, email, AIM and ICQs will be converted automatically.

Options:
Auto-BR (Line breaks become <br />)
Remember me (Set cookies for name, email & url)